Conspicuously, in PC-3 cells, UBE2C could recruit FOXA1 to its enhancers, that was mostly likely correlated with the expression of UBE2C [41] and promoted the progression of castration-resistant prostate cancer. Here, FOXA1 is linked to prostate carcinoma.